ストックスクリーナーアプリを入手
73.80
1.04%
0.76
プレマーケット:
73.56
-0.24
-0.33%
前日終値:
$73.04
開ける：
$72.77
24時間の取引高:
707.76K
Relative Volume:
0.84
時価総額：
$4.05B
収益：
$1.39B
当期純損益:
$-242.49M
株価収益率:
-16.49
EPS:
-4.4759
ネットキャッシュフロー:
$173.29M
1週間 パフォーマンス:
-0.04%
1か月 パフォーマンス:
+25.25%
6か月 パフォーマンス:
+15.66%
1年 パフォーマンス:
+70.95%
1日の値動き範囲:
$72.46
$74.25
1週間の範囲:
$70.74
$75.81
52週間の値動き範囲:
$41.02
$75.81
Livanova Plc Stock (LIVN) Company Profile
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
73.80 | 4.01B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
Did LivaNova's (LIVN) New Cardiopulmonary Chief from Philips Just Redefine Its Leadership Bench? - simplywall.st
Insider Sell Alert: Francesco Bianchi Sells Shares of LivaNova P - GuruFocus
LivaNova appoints Stefano Folli to lead its cardiopulmonary business unit - MSN
LivaNova Plc Hits New 52-Week High at USD 74.28 - Markets Mojo
LivaNova names Stefano Folli as president, CP - Medical Buyer
Why (LIVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LIVN Technical Analysis & Stock Price Forecast - Intellectia AI
LivaNova (LIVN) Edges Higher as Stock Tests Key Resistance at $77.52Dark Pool Prints - Newser
Paradice Investment Management LLC's LivaNova PLC(LIVN) Holding History - GuruFocus
LivaNova names Stefano Folli as cardiopulmonary president - Investing.com UK
LivaNova appoints Franco Poletti as President, Cardiopulmonary - TipRanks
LivaNova names Stefano Folli as cardiopulmonary president By Investing.com - Investing.com South Africa
LivaNova names Stefano Folli to head cardiopulmonary unit - StreetInsider
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit - Business Wire
LivaNova PLC Lifts 2026 Outlook After Strong Q1 - The Globe and Mail
LivaNova PLC stock (US5356991077): cardiac device specialist in focus after regulatory update and ea - AD HOC NEWS
LivaNova’s SWOT analysis: medical device stock eyes growth plan By Investing.com - Investing.com Nigeria
LivaNova’s SWOT analysis: medical device stock eyes growth plan - Investing.com
LivaNova stock hits 52-week high at 73.31 USD By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 73.31 USD - Investing.com
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June 2026 - BioSpace
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June - Business Wire
Will LivaNova's (LIVN) Return to Quarterly Profitability Reset Investor Expectations on Its Turnaround Narrative? - simplywall.st
LivaNova PLC stock (US5356991077): cardiac device maker updates investors after latest earnings - AD HOC NEWS
Total debt per share of LivaNova Plc – SWB:LIA - TradingView
LivaNova PLCOrdinary Shares (NQ: LIVN - FinancialContent
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ETFs Investing in LivaNova Plc Stocks - TradingView
LivaNova stock (US5356991077): Medical device leader with Nasdaq listing - AD HOC NEWS
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova (LIVN) Q3 2025 Earnings Transcript - AOL.com
LivaNova (LIVN) Stock Forum and Discussion - Moomoo
Drug Resistant Epilepsy Market to Reach US$ 1.28 Billion by 2033 - openPR.com
LivaNova stock hits 52-week high at 71.97 USD By Investing.com - Investing.com Nigeria
LivaNova PLC Lifts Guidance After Strong Q1 Call - TipRanks
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval - Yahoo Finance
LivaNova stock hits 52-week high at 71.97 USD - Investing.com India
LivaNova PLC 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-05-08 - Seeking Alpha
LivaNova PLC (LIVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Active Implantable Medical Devices Market Size is Anticipated - openPR.com
LIVN Maintained by Baird -- Price Target Lowered to $76.00 - GuruFocus
LIVN Maintained by Mizuho -- Price Target Raised to $90.00 - GuruFocus
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
1.94%
大文字化:
|
ボリューム (24 時間):